Figures & data
Figure 1 The ratios of Glx/Cr in the three brain regions.
Note: *P < 0.05.
Abbreviations: Glx, glutamate plus glutamine; Cr, creatine; F, frontal lobe; LB, left basal ganglia; O, parieto-occipital lobe; HC, healthy control; SC, early-stage first-episode schizophrenia.
Abbreviations: Glx, glutamate plus glutamine; Cr, creatine; F, frontal lobe; LB, left basal ganglia; O, parieto-occipital lobe; HC, healthy control; SC, early-stage first-episode schizophrenia.
![Figure 1 The ratios of Glx/Cr in the three brain regions.](/cms/asset/8beb91f0-a4a4-41dd-b906-6c78aa866c01/dndt_a_25582_f0001_c.jpg)
Figure 2 The changes in Glx/Cr before and 6 months after treatment with atypical antipsychotic drugs.
Note: *P < 0.05.
Abbreviations: Glx, glutamate plus glutamine; Cr, creatine; F, frontal lobe; LB, left basal ganglia; O, parieto-occipital lobe; B, before treatment with atypical antipsychotic drugs; 6M, 6 months after treatment with atypical antipsychotic drugs.
Abbreviations: Glx, glutamate plus glutamine; Cr, creatine; F, frontal lobe; LB, left basal ganglia; O, parieto-occipital lobe; B, before treatment with atypical antipsychotic drugs; 6M, 6 months after treatment with atypical antipsychotic drugs.
![Figure 2 The changes in Glx/Cr before and 6 months after treatment with atypical antipsychotic drugs.](/cms/asset/029b83c6-224d-4e26-9dba-e976191e727d/dndt_a_25582_f0002_c.jpg)